BioLineRx to Report Second Quarter 2024 Results on August 15, 2024
Go back to BioLineRx to Report Second Quarter 2024 Results on August 15, 2024| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.76 +0.06 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $1.63 | |||
| Open | $2.85 | 52 Week Low | $0.71 | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $0.00 | |||
| Volume | 2,271 | |||||
| BIOLINE RX SP ADR (NASDAQ: BLRX) | Delayed: 2.76 +0.06 (2.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.70 | 52 Week High | $1.63 | |||
| Open | $2.85 | 52 Week Low | $0.71 | |||
| Day High | $2.85 | P/E | N/A | |||
| Day Low | $2.76 | EPS | $0.00 | |||
| Volume | 2,271 | |||||

